chloroquine has been researched along with isobavachalcone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X | 1 |
| Liu, CX; Ma, CM; Sun, Y; Wei, W; Wu, YL; Yan, H; Zhao, S | 1 |
1 review(s) available for chloroquine and isobavachalcone
| Article | Year |
|---|---|
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries | 2020 |
1 other study(ies) available for chloroquine and isobavachalcone
| Article | Year |
|---|---|
Autophagy inhibition enhances isobavachalcone-induced cell death in multiple myeloma cells.
Topics: Adenine; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cells, Cultured; Chalcones; Chloroquine; Gene Knockdown Techniques; HEK293 Cells; Humans; Macrolides; Membrane Potential, Mitochondrial; Membrane Proteins; Mitochondria; Multiple Myeloma; Protein Kinase C-delta; Proteolysis | 2012 |